Company / Book Value per Share
Alaunos Therapeutics, Inc. Book Value per Share History
FY2012-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$1.288
FY2025
5-year range
$0.269 / $3.939
FY2021-FY2025
Trend
-67.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Book Value per Share has fluctuated over the past 10 years, ranging from -$0.601 in FY2019 to $3.939 in FY2024.
Based on SEC 10-K filings.
$1.288 in FY2025 with a 5-year CAGR of +19.8%.
Declined from $2.406 to $1.288 over the past 2 years.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- +68.6%
- 5-Year CAGR
- +19.8%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +19.8%, indicating consistent growth.
- In FY2025, book value per share decreased 67.3% year-over-year.
- Peak book value per share was recorded in FY2024.
- Lowest book value per share in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score -3.79 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.288 | -67.3% |
| FY2024 | $3.939 | +63.7% |
| FY2023 | $2.406 | +795.5% |
| FY2022 | $0.269 | -53.5% |
| FY2021 | $0.578 | +10.6% |
| FY2020 | $0.523 | +186.9% |
| FY2019 | -$0.601 | -10.9% |
| FY2018 | -$0.542 | -163.0% |
| FY2013 | $0.86 | +11807.3% |
| FY2012 | $0.007 | -30.0% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026